These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30978371)

  • 1. Loss of exercise- and stress-induced increases in circulating 2-arachidonoylglycerol concentrations in adults with chronic PTSD.
    Crombie KM; Leitzelar BN; Brellenthin AG; Hillard CJ; Koltyn KF
    Biol Psychol; 2019 Jul; 145():1-7. PubMed ID: 30978371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychobiological Responses to Aerobic Exercise in Individuals With Posttraumatic Stress Disorder.
    Crombie KM; Brellenthin AG; Hillard CJ; Koltyn KF
    J Trauma Stress; 2018 Feb; 31(1):134-145. PubMed ID: 29388710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks.
    Hill MN; Bierer LM; Makotkine I; Golier JA; Galea S; McEwen BS; Hillard CJ; Yehuda R
    Psychoneuroendocrinology; 2013 Dec; 38(12):2952-61. PubMed ID: 24035186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoids and Stress-Related Neurospsychiatric Disorders: A Systematic Review and Meta-Analysis of Basal Concentrations and Response to Acute Psychosocial Stress.
    Gowatch LC; Evanski JM; Ely SL; Zundel CG; Bhogal A; Carpenter C; Shampine MM; O'Mara E; Mazurka R; Barcelona J; Mayo LM; Marusak HA
    Cannabis Cannabinoid Res; 2024 Oct; 9(5):1217-1234. PubMed ID: 38683635
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide).
    Hanlon EC
    Psychoneuroendocrinology; 2020 Jan; 111():104471. PubMed ID: 31610409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating endocannabinoids and psychological outcomes in women with PTSD.
    Botsford C; Brellenthin AG; Cisler JM; Hillard CJ; Koltyn KF; Crombie KM
    J Anxiety Disord; 2023 Jan; 93():102656. PubMed ID: 36469982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors.
    Yi B; Nichiporuk I; Nicolas M; Schneider S; Feuerecker M; Vassilieva G; Thieme D; Schelling G; Choukèr A
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jun; 67():92-7. PubMed ID: 26780604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder.
    Meyer JD; Crombie KM; Cook DB; Hillard CJ; Koltyn KF
    Med Sci Sports Exerc; 2019 Sep; 51(9):1909-1917. PubMed ID: 30973483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress.
    Hill MN; Miller GE; Carrier EJ; Gorzalka BB; Hillard CJ
    Psychoneuroendocrinology; 2009 Sep; 34(8):1257-62. PubMed ID: 19394765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid and Mood Responses to Exercise in Adults with Varying Activity Levels.
    Brellenthin AG; Crombie KM; Hillard CJ; Koltyn KF
    Med Sci Sports Exerc; 2017 Aug; 49(8):1688-1696. PubMed ID: 28319590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women.
    Pastor A; Fernández-Aranda F; Fitó M; Jiménez-Murcia S; Botella C; Fernández-Real JM; Frühbeck G; Tinahones FJ; Fagundo AB; Rodriguez J; Agüera Z; Langohr K; Casanueva FF; de la Torre R
    PLoS One; 2016; 11(2):e0148734. PubMed ID: 26849214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention.
    Soldevila-Domenech N; Fagundo B; Cuenca-Royo A; Forcano L; Gomis-González M; Boronat A; Pastor A; Castañer O; Zomeño MD; Goday A; Dierssen M; Baghizadeh Hosseini K; Ros E; Corella D; Martínez-González MÁ; Salas-Salvadó J; Fernández-Aranda F; Fitó M; de la Torre R
    Nutr J; 2024 Jun; 23(1):61. PubMed ID: 38862960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder.
    Hauer D; Schelling G; Gola H; Campolongo P; Morath J; Roozendaal B; Hamuni G; Karabatsiakis A; Atsak P; Vogeser M; Kolassa IT
    PLoS One; 2013; 8(5):e62741. PubMed ID: 23667516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism.
    Navarini L; Bisogno T; Mozetic P; Piscitelli F; Margiotta DPE; Basta F; Afeltra A; Maccarrone M
    Int J Biochem Cell Biol; 2018 Jun; 99():161-168. PubMed ID: 29655919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis.
    Sanchez AM; Cioffi R; Viganò P; Candiani M; Verde R; Piscitelli F; Di Marzo V; Garavaglia E; Panina-Bordignon P
    Reprod Sci; 2016 Aug; 23(8):1071-9. PubMed ID: 26887427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa.
    Monteleone AM; Di Marzo V; Aveta T; Piscitelli F; Dalle Grave R; Scognamiglio P; El Ghoch M; Calugi S; Monteleone P; Maj M
    Am J Clin Nutr; 2015 Feb; 101(2):262-9. PubMed ID: 25646322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders.
    Schaefer C; Enning F; Mueller JK; Bumb JM; Rohleder C; Odorfer TM; Klosterkötter J; Hellmich M; Koethe D; Schmahl C; Bohus M; Leweke FM
    Eur Arch Psychiatry Clin Neurosci; 2014 Aug; 264(5):459-63. PubMed ID: 24253425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression.
    Heyman E; Gamelin FX; Goekint M; Piscitelli F; Roelands B; Leclair E; Di Marzo V; Meeusen R
    Psychoneuroendocrinology; 2012 Jun; 37(6):844-51. PubMed ID: 22029953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Systematic Review and Meta-Analysis on the Effects of Exercise on the Endocannabinoid System.
    Desai S; Borg B; Cuttler C; Crombie KM; Rabinak CA; Hill MN; Marusak HA
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):388-408. PubMed ID: 34870469
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating Endocannabinoids and Mortality in Hemodialysis Patients.
    Moradi H; Park C; Streja E; Argueta DA; DiPatrizio NV; You AS; Rhee CM; Vaziri ND; Kalantar-Zadeh K; Piomelli D
    Am J Nephrol; 2020; 51(2):86-95. PubMed ID: 31935741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.